Funding Calls Database

Filter by

Project Categories














Funding Categories



Applicant Categories







Geographical Scope










Disease areas



















Call status






Languages




25 Result(s)
Status: Closed for submission

Bridging the gap
Type of projectClinical trial - any phaseIn vitro/in vivo candidate validation
Disease area(s)Neuromuscular disorders
Type of applicantAcademic
Application deadline full proposal

March 26, 2024

Status: Grants announced

DEBRA UK
Type of projectAll
Disease area(s)Dermatology
Type of applicantAcademic
Application deadline full proposal

March 31, 2024

Status: Closed for submission

DEBRA UK small
Type of projectPilot study
Disease area(s)All
Type of applicantAcademicClinical
Application deadline full proposal

March 31, 2024

Status: Open for submission

Drug development project
Type of projectClinical trial (early phase – dose, toxicity etc)Clinical trial (efficacy – Phase 2)In vitro/in vivo candidate validation
Disease area(s)Oncology
Type of applicantAcademicClinicalSME/Company
Application deadline full proposal

May 13, 2024

Status: Closed for submission

Biology to prevention award
Type of projectClinical trial - any phaseIn vitro/in vivo candidate validationPilot study
Disease area(s)Oncology
Type of applicantAcademicClinical
Application deadline full proposal

June 20, 2024

Status: Open for submission

UKRI Developmental pathway funding scheme
Type of projectClinical trial (early phase – dose, toxicity etc)Clinical trial (efficacy – Phase 2)In vitro/in vivo candidate validation
Disease area(s)All
Type of applicantAcademic
Application deadline full proposal

July 6, 2024

Status: Open for submission

UKRI Experimental medicine
Type of projectAll
Disease area(s)All
Type of applicantAcademic
Application deadline full proposal

July 9, 2024

Status: Open for submission

GGG DR
Type of projectClinical trial - any phaseProof of concept
Disease area(s)All
Type of applicantAcademicClinicalOtherPatient organisation
Application deadline full proposal

October 1, 2024

REMEDi4ALL Partners & Associated partners

Anticancer Fund (ACF) - Belgium
FIMM Institute for Molecular Medicine Finland
University of Helsinki
Istituto Ortopedico Rizzoli (IOR) - Italy
Bundesinstitut Fur Arzneimittel Und Medizinprodukte (BFARM) - Germany
Dompé farmaceutici Spa (DOMPÉ) – Italy
EATRIS (Coordinator) – The Netherlands
Fraunhofer-Gesellschaft – Germany
University Of Hull (UHULL) – United Kingdom
Istituto Di Ricerche Farmacologiche Mario Negri (IRFMN) - Italy
Karolinska Institutet (KI) - Sweden
The University Of Sheffield (USFD) - United Kingdom
Universitaetsmedizin Goettingen (UMG) - Germany
Uppsala Universitet (UU) - Sweden
Beacon: For Rare Diseases (BEACON) - United Kingdom
European Clinical Research Infrastructure Network (ECRIN) - France
European Organisation For Rare Diseases Association (EURORDIS) – France
Istituto Nazionale Tumori Fondazione Pascale (INT-NA) - Italy
Medicines For Europe (M4EU) - Belgium
Servicio Madrileño De Salud (SERMAS) - Spain
Syreon Kutato Intezet Korlatolt Felelossegu Tarsasag (SRI) - Hungary
Univerza V Ljubljani - Slovenia
ZonMw (Zorgonderzoek Nederland Zon) (ZONMW) - Netherlands